Literature DB >> 15255798

Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups.

Jian-ping Zhang1, Yong-yuan Guan, Jue-heng Wu, An-long Xu, Shufeng Zhou, Min Huang.   

Abstract

AIMS: Ethnicity is an important variable influencing drug response. Thiopurine S-methyltransferase (TPMT) plays an important role in the metabolism of thiopurine drugs. Previous population studies have identified ethnic variations in both phenotype and genotype of TPMT, but limited information is available within Chinese population that comprises at least 56 ethnic groups. The current study was conducted to compare both phenotype and genotype of TPMT in healthy Han and Yao Chinese children.
METHODS: TPMT activity was measured in healthy Chinese children by a HPLC assay (n = 213, 87 Han Chinese and 126 Yao Chinese). Allele-specific polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (RFLP) were used to determine the frequency of TPMT mutant alleles (TPMT*2, TPMT*3 A, TPMT*3B and TPMT*3C) in these children.
RESULTS: There was no significant difference in the mean TPMT activity between Han and Yao Chinese children. A unimodal distribution of TPMT activity in Chinese children was found and the mean TPMT activity was 13.32 +/- 3.49 U ml(-1) RBC. TPMT activity was not found to differ with gender, but tended to increase with age in Yao Chinese children. TPMT*2, TPMT*3B and TPMT*3A were not detected, and only one TPMT*3C heterozygote (Han child) was identified in 213 Chinese children. Erythrocyte TPMT activity of this TPMT*3C heterozygote was 12.36 U ml(-1) RBC. The frequency of the known mutant TPMT alleles was 0.2%[1/426] in Chinese children.
CONCLUSION: The frequency distribution of RBC TPMT activity was unimodal. The frequency of the known mutant TPMT alleles in Chinese Children is low and TPMT*3C appears to be the most prevalent among the tested mutant TPMT alleles in this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255798      PMCID: PMC1884582          DOI: 10.1111/j.1365-2125.2004.02113.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  36 in total

1.  Racial differences in the response to drugs--pointers to genetic differences.

Authors:  A J Wood
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

2.  Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy.

Authors:  J F Colombel; N Ferrari; H Debuysere; P Marteau; J P Gendre; B Bonaz; J C Soulé; R Modigliani; Y Touze; P Catala; C Libersa; F Broly
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  A comparison of molecular and enzyme-based assays for the detection of thiopurine methyltransferase mutations.

Authors:  S A Coulthard; C Rabello; J Robson; C Howell; L Minto; P G Middleton; M K Gandhi; G Jackson; J McLelland; H O'Brien; S Smith; M M Reid; A D Pearson; A G Hall
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

4.  Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity.

Authors:  D M Otterness; C L Szumlanski; T C Wood; R M Weinshilboum
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

5.  Thioguanine substitution alters DNA cleavage mediated by topoisomerase II.

Authors:  N F Krynetskaia; X Cai; J L Nitiss; E Y Krynetski; M V Relling
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

6.  Thiopurine pharmacogenetics: clinical and molecular studies of thiopurine methyltransferase.

Authors:  R Weinshilboum
Journal:  Drug Metab Dispos       Date:  2001-04       Impact factor: 3.922

7.  Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.

Authors:  L Yan; S Zhang; B Eiff; C L Szumlanski; M Powers; J F O'Brien; R M Weinshilboum
Journal:  Clin Pharmacol Ther       Date:  2000-08       Impact factor: 6.875

Review 8.  Genetic polymorphism of thiopurine S-methyltransferase: molecular mechanisms and clinical importance.

Authors:  E Y Krynetski; W E Evans
Journal:  Pharmacology       Date:  2000-09       Impact factor: 2.547

9.  [The study on hereditary polymorphism of thiopurine S-methyltransferasein Chinese Han population of Shanghai area].

Authors:  Q Ye; L Gu; J Zhao; A Liang; Y Ye
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2000-12

10.  Genetic analysis of thiopurine methyltransferase polymorphism in a Japanese population.

Authors:  M Hiratsuka; T Inoue; F Omori; Y Agatsuma; M Mizugaki
Journal:  Mutat Res       Date:  2000-03-14       Impact factor: 2.433

View more
  10 in total

1.  Phenotyping and genotyping studies of thiopurine S-methyltransferase in Kazaks.

Authors:  Hong Wei; Shufeng Zhou; Chengrong Li; Jianping Zhang; Jueheng Wu; Min Huang
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

2.  Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.

Authors:  Dongying Chen; Fan Lian; Shiwen Yuan; Yixi Wang; Zhongping Zhan; Yujin Ye; Qian Qiu; Hanshi Xu; Liuqin Liang; Xiuyan Yang
Journal:  Clin Rheumatol       Date:  2013-12-10       Impact factor: 2.980

3.  Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore.

Authors:  Shirley Kow Yin Kham; Chin Kok Soh; Te Chih Liu; Yiong Huak Chan; Hany Ariffin; Poh Lin Tan; Allen Eng Juh Yeoh
Journal:  Eur J Clin Pharmacol       Date:  2008-01-11       Impact factor: 2.953

4.  Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study.

Authors:  Zhang Fangbin; Gao Xiang; Ding Liang; Liu Hui; Wang Xueding; Chen Baili; Bi Huichang; Xiao Yinglian; Cheng Peng; Zhao Lizi; Chu Yanjun; Xu Feng; Chen Minhu; Huang Min; Hu Pinjin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

5.  Comparison of Direct Sequencing, Real-Time PCR-High Resolution Melt (PCR-HRM) and PCR-Restriction Fragment Length Polymorphism (PCR-RFLP) Analysis for Genotyping of Common Thiopurine Intolerant Variant Alleles NUDT15 c.415C>T and TPMT c.719A>G (TPMT*3C).

Authors:  Wai-Ying Fong; Chi-Chun Ho; Wing-Tat Poon
Journal:  Diagnostics (Basel)       Date:  2017-05-12

Review 6.  Clinical pharmacology and pharmacogenetics of thiopurines.

Authors:  Srikumar Sahasranaman; Danny Howard; Sandip Roy
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 3.064

7.  Thiopurine methyltransferase genotyping in Palestinian childhood acute lymphoblastic leukemia patients.

Authors:  Basim Mohammad Ayesh; Wael Mohammad Harb; Abdalla Assaf Abed
Journal:  BMC Hematol       Date:  2013-04-10

8.  Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population.

Authors:  Hamza Ben Zeglam; Abdrazak Benhamer; Adel Aboud; Haitem Rtemi; Meftah Mattardi; Saleh Suleiman Saleh; Abdullah Bashein; Nabil Enattah
Journal:  Libyan J Med       Date:  2015-03-26       Impact factor: 1.743

9.  Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan

Authors:  Mervat Alsous; Al-Motassem Yousef; Mariam Abdel Jalil; Mohammed Zawiah; Shorouq Yacoub; Deema Momani; Alia Gharabli; Suha Omar; Rawad Rihani
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

Review 10.  Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring.

Authors:  Sheng Zhang Lim; Eng Wee Chua
Journal:  Front Pharmacol       Date:  2018-10-08       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.